COMPASS Pathways Announces Phase 3 Pivotal Program Design for COMP360 in Treatment Resistant Depression at Capital Markets Day - GlobeNewswire

Submitted by Anonymous (not verified) on Wed, 10/12/2022 - 15:00

COMPASS Pathways Announces Phase 3 Pivotal Program Design for COMP360 in Treatment Resistant Depression at Capital Markets Day  GlobeNewswire